Article
Preimplantation genetic diagnosis as a source of human embryonic stem cells for disease research and drug discovery
12 Dec 2008
Abstract excerpt
Embryos surplus to therapeutic requirements following preimplantation genetic diagnosis can be used to derive human embryonic stem cell (hESC) lines carrying mutations significant to human disease. These cells provide a powerful in vitro tool for modelling disease progression in a number of cell types as well as having the potential to revolutionise drug discovery. Robust and reproducible directed differentiation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
